These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6541793)

  • 21. Comparison of behavioural effects of repeated treatment with methamphetamine plus scopolamine and methamphetamine alone on behavioural sensitization and conditioned response.
    Yui K; Miura T; Sugiyama K; Ono M; Nagase M
    J Pharm Pharmacol; 1995 Oct; 47(10):852-6. PubMed ID: 8583355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS; Joyce JN
    Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modification of dyskinesias following the intrastriatal injection of prostaglandins in the rodent.
    Costall B; Holmes SW; Kelly ME; Naylor RJ
    Br J Pharmacol; 1985 Aug; 85(4):943-9. PubMed ID: 3862460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Key role of striatal cholinergic interneurons in processes leading to arrest of motor stereotypies.
    Aliane V; Pérez S; Bohren Y; Deniau JM; Kemel ML
    Brain; 2011 Jan; 134(Pt 1):110-8. PubMed ID: 21097493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysregulation of gene induction in corticostriatal circuits after repeated methylphenidate treatment in adolescent rats: differential effects on zif 268 and homer 1a.
    Cotterly L; Beverley JA; Yano M; Steiner H
    Eur J Neurosci; 2007 Jun; 25(12):3617-28. PubMed ID: 17610581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scopolamine augments c-fos and zip/268 messenger RNA expression induced by the full D(1) dopamine receptor agonist SKF-82958 in the intact rat striatum.
    Wang JQ; McGinty JF
    Neuroscience; 1996 Jun; 72(3):601-16. PubMed ID: 8861055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereotyped behavioral responses to an auditory stimulus in the course of repeated treatment with methamphetamine plus scopolamine and methamphetamine in rats.
    Yui K; Miura T; Sugiyama K; Ono M; Nagase M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Jun; 14(3):169-78. PubMed ID: 7941782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scopolamine modulates apomorphine-induced behavior in rats treated with haloperidol or SCH 23390.
    Butkerait P; Friedman E
    Eur J Pharmacol; 1988 Mar; 148(2):269-72. PubMed ID: 2897925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased striatal dopamine efflux follows scopolamine administered systemically or to the tegmental pedunculopontine nucleus.
    Chapman CA; Yeomans JS; Blaha CD; Blackburn JR
    Neuroscience; 1997 Jan; 76(1):177-86. PubMed ID: 8971770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of scopolamine on the EEG of cortex and hippocampus during spontaneous behaviour in rats.
    Irmis F
    Act Nerv Super (Praha); 1974 Aug; 16(3):220-2. PubMed ID: 4418718
    [No Abstract]   [Full Text] [Related]  

  • 31. Dopaminergic and muscarinic regulation of striatal enkephalin and substance P messenger RNAs following striatal dopamine denervation: effects of systemic and central administration of quinpirole and scopolamine.
    Nisenbaum LK; Kitai ST; Gerfen CR
    Neuroscience; 1994 Nov; 63(2):435-49. PubMed ID: 7534387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence that nigral GABA mediates behavioural responses elicited by striatal dopamine receptor stimulation.
    Di Chiara G; Morelli M; Porceddu ML; Gessa GL
    Life Sci; 1978 Nov; 23(20):2045-51. PubMed ID: 569236
    [No Abstract]   [Full Text] [Related]  

  • 33. Methamphetamine plus scopolamine potentiates behavioral sensitization and conditioning.
    Yui K; Miura T; Sugiyama K; Ono M; Nagase M
    Eur J Pharmacol; 1995 Jun; 279(2-3):135-42. PubMed ID: 7556393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of rivastigmine on scopolamine-induced memory impairment in rats.
    Bejar C; Wang RH; Weinstock M
    Eur J Pharmacol; 1999 Nov; 383(3):231-40. PubMed ID: 10594314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of calcium-independent phospholipase A2 in cortex striatum thalamus cortex circuitry-enzyme inhibition causes vacuous chewing movements in rats.
    Lee LY; Ong WY; Farooqui AA; Burgunder JM
    Psychopharmacology (Berl); 2007 Dec; 195(3):387-95. PubMed ID: 17768607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term neurochemical and behavioral effects induced by acute chlorpyrifos treatment.
    Pope CN; Chakraborti TK; Chapman ML; Farrar JD
    Pharmacol Biochem Behav; 1992 Jun; 42(2):251-6. PubMed ID: 1378635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Digiscan activity: automated measurement of thigmotactic and stereotypic behavior in rats.
    Sanberg PR; Zoloty SA; Willis R; Ticarich CD; Rhoads K; Nagy RP; Mitchell SG; Laforest AR; Jenks JA; Harkabus LJ
    Pharmacol Biochem Behav; 1987 Jul; 27(3):569-72. PubMed ID: 3659082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism.
    Gray AM; Connick JH
    Eur J Pharmacol; 1998 Dec; 362(2-3):127-36. PubMed ID: 9874162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripherally injected scopolamine differentially modulates acetylcholine release in vivo in the young and aged rats.
    Scali C; Vannucchi MG; Pepeu G; Casamenti F
    Neurosci Lett; 1995 Sep; 197(3):171-4. PubMed ID: 8552291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of different sections of the striatum in rats in organizing minute fluctuations of stereotyped behavior and tolerance to the use of fenamine].
    Arushanian EB; Popov AV
    Biull Eksp Biol Med; 1991 Mar; 111(3):277-9. PubMed ID: 2054503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.